Literature DB >> 11040156

Paraparesis, hypermanganesaemia, and polycythaemia: a novel presentation of cirrhosis.

S M Gospe1, R D Caruso, M S Clegg, C L Keen, N R Pimstone, J M Ducore, S S Gettner, R A Kreutzer.   

Abstract

Progressive myelopathy is a rare complication of chronic hepatic disease which has never been reported in the paediatric age group. We describe the 11 year course of an adolescent male with hepatic myelopathy caused by cryptogenic micronodular cirrhosis. His condition has been associated with persistent polycythaemia and extraordinary increases of whole blood manganese, with magnetic resonance imaging evidence of manganese deposition within the basal ganglia and other regions of the brain. The patient has developed neither liver failure nor parkinsonism. The pathophysiological bases of this multiorgan system disorder are described.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11040156      PMCID: PMC1718535          DOI: 10.1136/adc.83.5.439

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  21 in total

Review 1.  Regulation of the erythropoietin gene.

Authors:  B L Ebert; H F Bunn
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

2.  Brain MR imaging in patients with hepatic cirrhosis: relationship between high intensity signal in basal ganglia on T1-weighted images and elemental concentrations in brain.

Authors:  H Maeda; M Sato; A Yoshikawa; M Kimura; T Sonomura; M Terada; K Kishi
Journal:  Neuroradiology       Date:  1997-08       Impact factor: 2.804

3.  Basal ganglial signal intensity alterations: reversal after discontinuation of parenteral manganese administration.

Authors:  S A Mirowitz; T J Westrich
Journal:  Radiology       Date:  1992-11       Impact factor: 11.105

4.  Spastic paraparesis associated with portal-systemic venous shunting due to congenital hepatic fibrosis.

Authors:  M Demirci; E Tan; B Elibol; G Gedikoğlu; O Saribaş
Journal:  Neurology       Date:  1992-05       Impact factor: 9.910

5.  Improvement of hepatic myelopathy after liver transplantation.

Authors:  R Troisi; J Debruyne; B de Hemptinne
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

6.  Chronic manganese intoxication.

Authors:  C C Huang; N S Chu; C S Lu; J D Wang; J L Tsai; J L Tzeng; E C Wolters; D B Calne
Journal:  Arch Neurol       Date:  1989-10

7.  Analysis of whole blood manganese by flameless atomic absorption spectrophotometry and its use as an indicator of manganese status in animals.

Authors:  M S Clegg; B Lönnerdal; L S Hurley; C L Keen
Journal:  Anal Biochem       Date:  1986-08-15       Impact factor: 3.365

8.  Ccute manganese overload. A new experimental model of intrahepatic cholestasis.

Authors:  C L Witzleben; P Pitlick; J Bergmeyer; R Benoit
Journal:  Am J Pathol       Date:  1968-09       Impact factor: 4.307

9.  Cloning and characterization of a mammalian proton-coupled metal-ion transporter.

Authors:  H Gunshin; B Mackenzie; U V Berger; Y Gunshin; M F Romero; W F Boron; S Nussberger; J L Gollan; M A Hediger
Journal:  Nature       Date:  1997-07-31       Impact factor: 49.962

10.  Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction.

Authors:  C Rose; R F Butterworth; J Zayed; L Normandin; K Todd; A Michalak; L Spahr; P M Huet; G Pomier-Layrargues
Journal:  Gastroenterology       Date:  1999-09       Impact factor: 22.682

View more
  19 in total

1.  Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease.

Authors:  Marialuisa Quadri; Antonio Federico; Tianna Zhao; Guido J Breedveld; Carla Battisti; Cathérine Delnooz; Lies-Anne Severijnen; Lara Di Toro Mammarella; Andrea Mignarri; Lucia Monti; Antioco Sanna; Peng Lu; Francesca Punzo; Giovanni Cossu; Rob Willemsen; Fabrizio Rasi; Ben A Oostra; Bart P van de Warrenburg; Vincenzo Bonifati
Journal:  Am J Hum Genet       Date:  2012-02-16       Impact factor: 11.025

2.  Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man.

Authors:  Karin Tuschl; Peter T Clayton; Sidney M Gospe; Shamshad Gulab; Shahnaz Ibrahim; Pratibha Singhi; Roosy Aulakh; Reinaldo T Ribeiro; Orlando G Barsottini; Maha S Zaki; Maria Luz Del Rosario; Sarah Dyack; Victoria Price; Andrea Rideout; Kevin Gordon; Ron A Wevers; W K Kling Chong; Philippa B Mills
Journal:  Am J Hum Genet       Date:  2012-02-16       Impact factor: 11.025

Review 3.  Familial manganese-induced neurotoxicity due to mutations in SLC30A10 or SLC39A14.

Authors:  Somshuvra Mukhopadhyay
Journal:  Neurotoxicology       Date:  2017-08-05       Impact factor: 4.294

Review 4.  Manganese homeostasis in the nervous system.

Authors:  Pan Chen; Sudipta Chakraborty; Somshuvra Mukhopadhyay; Eunsook Lee; Monica M B Paoliello; Aaron B Bowman; Michael Aschner
Journal:  J Neurochem       Date:  2015-06-16       Impact factor: 5.372

Review 5.  Diagnosis of inherited disorders of liver metabolism.

Authors:  P T Clayton
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 6.  Manganese-Induced Parkinsonism Is Not Idiopathic Parkinson's Disease: Environmental and Genetic Evidence.

Authors:  Tomás R Guilarte; Kalynda K Gonzales
Journal:  Toxicol Sci       Date:  2015-08       Impact factor: 4.849

Review 7.  Brain manganese and the balance between essential roles and neurotoxicity.

Authors:  Rekha C Balachandran; Somshuvra Mukhopadhyay; Danielle McBride; Jennifer Veevers; Fiona E Harrison; Michael Aschner; Erin N Haynes; Aaron B Bowman
Journal:  J Biol Chem       Date:  2020-03-18       Impact factor: 5.157

Review 8.  Spinal cord involvement in patients with cirrhosis.

Authors:  Raffaele Nardone; Yvonne Höller; Monica Storti; Piergiorgio Lochner; Frediano Tezzon; Stefan Golaszewski; Francesco Brigo; Eugen Trinka
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

9.  Hepatic cirrhosis, dystonia, polycythaemia and hypermanganesaemia--a new metabolic disorder.

Authors:  Karin Tuschl; Philippa B Mills; Howard Parsons; Marian Malone; Darren Fowler; Maria Bitner-Glindzicz; Peter T Clayton
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

10.  Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder.

Authors:  Maria Stamelou; Karin Tuschl; W K Chong; Andrew K Burroughs; Philippa B Mills; Kailash P Bhatia; Peter T Clayton
Journal:  Mov Disord       Date:  2012-08-23       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.